Published: 23-07-2014
Review
Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies
Abstract 161 | PDF Downloads 197Page 82-90
Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis
Abstract 305 | PDF Downloads 164Page 91-107
The value of chest radiograph and computed tomography in pulmonary sarcoidosis
Abstract 135 | PDF Downloads 400Page 108-116
Original Articles: Clinical Research
Association between physical functions and quality of life in sarcoidosis
Abstract 232 | PDF Downloads 113Page 117-128
Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre
Abstract 137 | PDF Downloads 69Page 129-135
Lack of correlation of BTNL2 polymorphism and cancer risk in sarcoidosis. BTNL2 and cancer risk in sarcoidosis
Abstract 179 | PDF Downloads 93Page 136-141
Sarcoidosis and Purified Protein Derivative reactivity
Abstract 113 | PDF Downloads 99 PDF Downloads 130Page 142-148
Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival
Abstract 88 | PDF Downloads 124Page 149-153
Could HLA-DR B1*11 allele be a clue for predicting extra-pulmonary sarcoidosis?
Abstract 139 | PDF Downloads 79Page 154-162
Unsuspected Exposure to Beryllium: Potential Implications for Sarcoidosis Diagnoses
Abstract 173 | PDF Downloads 66Page 163-169
Case Reports
Metformin/glibenclamide-related interstitial lung disease: a case report
Abstract 162 | PDF Downloads 131Page 170-173
Errata corrige
Errata Corrige: Sarcoidosis Vasc Diffuse Lung Dis 2014; 31; Suppl. 1; 3. The clinical and integrated management of COPD.
Abstract 92 | PDF Downloads 54Page 174